@article{1a184235065f492cb49e8de919b5631b,
title = "Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer",
keywords = "Lung cancer, Malignant effusion, Oncolytic virotherapy, VEGF",
author = "Stephanie Weibel and Elisabeth Hofmann and Basse-Luesebrink, \{Thomas Christian\} and Ulrike Donat and Carolin Seubert and Marion Adelfinger and Prisca Gnamlin and Christina Kober and Alexa Frentzen and Ivaylo Gentschev and Jakob, \{Peter Michael\} and Szalay, \{Aladar A.\}",
note = "Funding Information: SW, EH, UD, and CS received a postdoctoral fellowship, TCBL, MA, and PG received a graduate fellowship from a service grant provided by Genelux Corporation awarded to the University of Wuerzburg, Germany. AF, IG and AAS are salaried employees of Genelux Corporation and have personal financial interests in Genelux Corporation. The funders had no role in study design, data collection and analysis or decision to publish. This work was supported by a research grant and a service grant from Genelux Corporation (R\&D facility in San Diego, CA, USA) awarded to the University of Wuerzburg, Germany.",
year = "2013",
month = may,
day = "1",
doi = "10.1186/1479-5876-11-106",
language = "English",
volume = "11",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
number = "1",
}